205 related articles for article (PubMed ID: 11161159)
1. Intramedullary and spinal canal tumors in patients with neurofibromatosis 2: MR imaging findings and correlation with genotype.
Patronas NJ; Courcoutsakis N; Bromley CM; Katzman GL; MacCollin M; Parry DM
Radiology; 2001 Feb; 218(2):434-42. PubMed ID: 11161159
[TBL] [Abstract][Full Text] [Related]
2. Spinal tumors in neurofibromatosis type 2. Is emerging knowledge of genotype predictive of natural history?
Dow G; Biggs N; Evans G; Gillespie J; Ramsden R; King A
J Neurosurg Spine; 2005 May; 2(5):574-9. PubMed ID: 15945431
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value and management of spinal tumors in neurofibromatosis type 2 patients.
Aboukais R; Baroncini M; Zairi F; Bonne NX; Schapira S; Vincent C; Lejeune JP
Acta Neurochir (Wien); 2013 May; 155(5):771-7. PubMed ID: 23381342
[TBL] [Abstract][Full Text] [Related]
4. Spinal tumors in patients with neurofibromatosis type 2: MR imaging study of frequency, multiplicity, and variety.
Mautner VF; Tatagiba M; Lindenau M; Fünsterer C; Pulst SM; Baser ME; Kluwe L; Zanella FE
AJR Am J Roentgenol; 1995 Oct; 165(4):951-5. PubMed ID: 7676998
[TBL] [Abstract][Full Text] [Related]
5. Further genotype--phenotype correlations in neurofibromatosis 2.
Selvanathan SK; Shenton A; Ferner R; Wallace AJ; Huson SM; Ramsden RT; Evans DG
Clin Genet; 2010 Feb; 77(2):163-70. PubMed ID: 19968670
[TBL] [Abstract][Full Text] [Related]
6. [Phenotype-genotype study in 154 French NF2 mutation carriers].
Demange L; De Moncuit C; Thomas G; Olschwang S
Rev Neurol (Paris); 2007 Nov; 163(11):1031-8. PubMed ID: 18033041
[TBL] [Abstract][Full Text] [Related]
7. Management of spinal tumors in neurofibromatosis type 2 patients.
Nowak A; Dziedzic T; Czernicki T; Kunert P; Marchel A
Neurol Neurochir Pol; 2016; 50(1):31-5. PubMed ID: 26851687
[TBL] [Abstract][Full Text] [Related]
8. Impairment of cell adhesion by expression of the mutant neurofibromatosis type 2 (NF2) genes which lack exons in the ERM-homology domain.
Koga H; Araki N; Takeshima H; Nishi T; Hirota T; Kimura Y; Nakao M; Saya H
Oncogene; 1998 Aug; 17(7):801-10. PubMed ID: 9779996
[TBL] [Abstract][Full Text] [Related]
9. MR imaging of myxopapillary ependymoma: findings and value to determine extent of tumor and its relation to intraspinal structures.
Wippold FJ; Smirniotopoulos JG; Moran CJ; Suojanen JN; Vollmer DG
AJR Am J Roentgenol; 1995 Nov; 165(5):1263-7. PubMed ID: 7572515
[TBL] [Abstract][Full Text] [Related]
10. Growth dynamics of intramedullary spinal tumors in patients with neurofibromatosis type 2.
Lawson McLean AC; Rosahl SK
Clin Neurol Neurosurg; 2016 Jul; 146():130-7. PubMed ID: 27208873
[TBL] [Abstract][Full Text] [Related]
11. Intracranial meningiomas and neurofibromatosis type 2.
Aboukais R; Zairi F; Baroncini M; Bonne NX; Schapira S; Vincent C; Lejeune JP
Acta Neurochir (Wien); 2013 Jun; 155(6):997-1001; discussion 1001. PubMed ID: 23558725
[TBL] [Abstract][Full Text] [Related]
12. Intramedullary tumours in patients with neurofibromatosis type 2: MRI features associated with a favourable prognosis.
Rennie AT; Side L; Kerr RS; Anslow P; Pretorius P
Clin Radiol; 2008 Feb; 63(2):193-200. PubMed ID: 18194696
[TBL] [Abstract][Full Text] [Related]
13. Tanycytic ependymoma in association with neurofibromatosis type 2.
Kobata H; Kuroiwa T; Isono N; Nagasawa S; Ohta T; Tsutsumi A
Clin Neuropathol; 2001; 20(3):93-100. PubMed ID: 11430494
[TBL] [Abstract][Full Text] [Related]
14. Intramedullary spinal cord tumors in neurofibromatosis.
Lee M; Rezai AR; Freed D; Epstein FJ
Neurosurgery; 1996 Jan; 38(1):32-7. PubMed ID: 8747948
[TBL] [Abstract][Full Text] [Related]
15. Germ-line mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities.
Parry DM; MacCollin MM; Kaiser-Kupfer MI; Pulaski K; Nicholson HS; Bolesta M; Eldridge R; Gusella JF
Am J Hum Genet; 1996 Sep; 59(3):529-39. PubMed ID: 8751853
[TBL] [Abstract][Full Text] [Related]
16. Identification of NF2 germ-line mutations and comparison with neurofibromatosis 2 phenotypes.
Kluwe L; Bayer S; Baser ME; Hazim W; Haase W; Fünsterer C; Mautner VF
Hum Genet; 1996 Nov; 98(5):534-8. PubMed ID: 8882871
[TBL] [Abstract][Full Text] [Related]
17. Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas.
Ebert C; von Haken M; Meyer-Puttlitz B; Wiestler OD; Reifenberger G; Pietsch T; von Deimling A
Am J Pathol; 1999 Aug; 155(2):627-32. PubMed ID: 10433955
[TBL] [Abstract][Full Text] [Related]
18. Concordance of bilateral vestibular schwannoma growth and hearing changes in neurofibromatosis 2: neurofibromatosis 2 natural history consortium.
Fisher LM; Doherty JK; Lev MH; Slattery WH
Otol Neurotol; 2009 Sep; 30(6):835-41. PubMed ID: 19704365
[TBL] [Abstract][Full Text] [Related]
19. Correlation of nonsense and frameshift mutations with severity of retinal abnormalities in neurofibromatosis 2.
Feucht M; Kluwe L; Mautner VF; Richard G
Arch Ophthalmol; 2008 Oct; 126(10):1376-80. PubMed ID: 18852415
[TBL] [Abstract][Full Text] [Related]
20. NF2 and spinal tumors.
Parry DM
J Neurosurg Spine; 2006 Aug; 5(2):179; author reply 179. PubMed ID: 16925089
[No Abstract] [Full Text] [Related]
[Next] [New Search]
